PROXIDRUGS successful in Clusters4Future competition
2021/02/04 by GU/Feu
The PROXIDRUGS consortium has been selected for funding within the Clusters4Future initiative of the Federal Ministry of Education and Research (BMBF), which aims at promoting regional innovation networks for the benefit of economy and society. PROXIDRUGS will be funded with up to 15 Mio. € for the next three years as one of seven clusters selected for funding from a total of 137 applications.
The consortium concentrates on developing new treatments for diseases with high unmet medical need, based on the new concept of proximity induction. “This allows to tackle so far non-addressable proteins for drug discovery”, says Prof. Felix Hausch, core team leader from the Technical University of Darmstadt. “Proxidrugs open up exciting new therapeutic options in numerous diseases including cancer, neurodegeneration and infection”, explains cluster speaker Ivan Đikić from Goethe University Frankfurt.
PROXIDRUGS has been set up as a regional network of partners from academia and industry, covering the entire value chain from basic to translational research. Academic participants are based at Goethe University Frankfurt, TU Darmstadt, University of Heidelberg, the MPI of Biophysics and the Fraunhofer Institute for Translational Medicine and Pharmacology, and they are closely working together with major pharma partners.
At the Technical University of Darmstadt, the research group of Harald Kolmar, Alexander Löwer, Frederik Lermyte, and Felix Hausch will contribute to PROXIDRUGS, which will funded with up to 1.6 Mio. €. The translation towards innovative drugs will be further supported by the Innovations- und Gründungszentrum HIGHEST.
